Office of Technology Transfer – University of Michigan

RIP shRNA and Control shRNA OSCC (HSC-3) Cell Lines

Technology #4953

Questions about this technology? Ask a Technology Manager

Download Printable PDF

Yvonne Kapila
Managed By
Anne Juggernauth
Licensing and Market Specialist 734-936-9749


This is a research tool available for a materials license or material transfer agreement.


The HSC-3 oral squamouse cell carcinoma (OSCC) cell line has been stably suppressed in its expression of RIP, as well as stably transfected with the control vector.